Infliximab in the treatment of Crohn's disease.
Feagan
B
B
London Health Sciences Centre, London, Canada.
D000911:Antibodies, Monoclonal; D003424:Crohn Disease / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab